Orgenesis ( (ORGS) ) has released a notification of late filing.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Orgenesis Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The primary reason for the delay is the company’s focus on capital raising, which has diverted resources away from completing the necessary financial audits. Additionally, Orgenesis is facing challenges with its ability to continue as a going concern, which has contributed to the delay. The company does not expect to file the report within the 15-day extension period allowed under Rule 12b-25. Financially, Orgenesis anticipates a decrease in net loss for 2024 compared to 2023 due to reduced activities stemming from funding constraints. The company is actively working on compliance efforts, as indicated by the signature of Victor Miller, Chief Financial Officer, on the notification.
More about Orgenesis
YTD Price Performance: 13.95%
Average Trading Volume: 13,325
Technical Sentiment Signal: Buy
Current Market Cap: $12.66M
See more insights into ORGS stock on TipRanks’ Stock Analysis page.